quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:35:16·826d
SECFiling
AcelRx Pharmaceuticals Inc. logo

AcelRx Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

ACRX· AcelRx Pharmaceuticals Inc.
Health Care
Original source

Companies

  • ACRX
    AcelRx Pharmaceuticals Inc.
    Health Care

Recent analyst ratings

  • Aug 17UpdateHC Wainwright & Co.$5.00

Related

  • 13D/G799d
    SEC Form SC 13G/A filed by AcelRx Pharmaceuticals Inc. (Amendment)
  • SEC800d
    SEC Form EFFECT filed by AcelRx Pharmaceuticals Inc.
  • INSIDER800d
    Dasu Badri N covered exercise/tax liability with 1,618 shares, decreasing direct ownership by 9% to 17,153 units (SEC Form 4)
  • INSIDER800d
    Palmer Pamela P covered exercise/tax liability with 1,602 shares, decreasing direct ownership by 4% to 35,344 units (SEC Form 4)
  • INSIDER800d
    Asadorian Raffi covered exercise/tax liability with 1,790 shares, decreasing direct ownership by 8% to 20,291 units (SEC Form 4)
  • INSIDER800d
    Angotti Vincent J. covered exercise/tax liability with 7,043 shares, decreasing direct ownership by 7% to 94,762 units (SEC Form 4)
  • 13D/G800d
    SEC Form SC 13G/A filed by AcelRx Pharmaceuticals Inc. (Amendment)
  • SEC800d
    SEC Form 424B7 filed by AcelRx Pharmaceuticals Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022